Prognostic Value of Echocardiographic Indicators of Left Ventricular Systolic Function in Asymptomatic Dialysis Patients

Journal of the American Society of Nephrology

Volumn 15, Issue 4, 2004, Pages 1029-1037

  Zoccali, Carmine ^a,d   Benedetto, Francesco A ^b   Mallamaci, Francesca ^a   Tripepi, Giovanni ^a   Giacone, Giuseppe ^c   Cataliotti, Alessandro ^c   Seminara, Giuseppe ^c   Stancanelli, Benedetta ^c   Malatino, Lorenzo S ^c  

^a CNR   (Italy)

^b Morelli Hospital   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d Ospedali Riuniti Via Vallone Petrara   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; N(G),N(G) DIMETHYLARGININE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; HEMODIALYSIS PATIENT; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SECONDARY PREVENTION;

EID: 1642304976     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000117977.14912.91     Document Type: Article

References (36)

1. McMurray JV, McDonagh TA, Davie AP, Cleland JG, Francis CM, Morrison C: Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 19: 842-846, 1998
2. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47: 884-890, 1995
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5: 2024-2031, 1995
4. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11: 1277-1285, 1996
5. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Long term evolution of cardiomyopathy in dialysis patients. Kidney Int 54: 1720-1725, 1998
6. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS: Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 12: 2768-2774, 2001
7. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Dame B, Metivier F, Adda H, Safar ME: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12: 2759-2767, 2001
8. McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RS, Junor BJ, McMillan MA, Briggs JD: Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant 13: 1499-1505, 1998
9. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Serial change in echocardiographic parameters and cardiac failure in end stage renal disease. J Am Soc Nephrol 11: 912-916, 2000
10. Wang TJ, Levy D, Benjamin EJ, Vasan RS: The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med 138: 907-916, 2003
11. Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC: Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 219: 598-603, 1996
12. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH: Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25: 1056-1062, 1995
13. Teicholz LE, Kreulen T, Herman MW, Gorlin R: Problems in echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 37: 7-11, 1976
14. Shimizu G, Zile MR, Blaustein AS, Gaasch WH: Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: Overestimation of fiber velocities by conventional midwall measurements. Circulation 71: 266-272, 1985
15. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH: Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 93: 259-265, 1996
16. Ganau A, Devereux RB, Pickering TG, Roman MJ, Schnall PL, Santucci S, Spitzer MC, Laragh JH: Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 81: 25-36, 1990
17. Devereux RB, Roman MJ, Palmieri V, Okin PM, Boman K, Gerdts E, Nieminen MS, Papademetriou V, Wachtell K, Dahlof B: Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. J Hypertension 18: 1129-1138, 2000
18. Collet D: Modelling Survival Data in Medical Research. London, Chapmann & Hall, 1994, pp 72-85
19. Raine AE, Seymour AM, Roberts AF, Radda GK, Ledingham JG: Impairment of cardiac function and energetics in experimental renal failure. J Clin Invest 92: 2934-2940, 1993
20. Rambausek M, Kollmar S, Klug D, Mehls O, Ritz E: Regulation of myocardial isomyosin V1 in uremic rats. Eur J Clin Invest 21: 64-71, 1991
21. Kennedy D, Omran E, Periyasamy SM, Nadoor J, Priyadarshi A, Willey JC, Malhotra D, Xie Z, Shapiro JI: Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol 14: 90-97, 2003
22. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC, American College of Cardiology, American Heart Association. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant 21: 189-203, 2002
23. Fathi R, Isbel N, Haluska B, Case C, Johnson DW, Marwick TH: Correlates of subclinical left ventricular dysfunction in ESRD. Am J Kidney Dis 41: 1016-1025, 2003
24. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR: Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107: 864-868, 2003
25. Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe DN: Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 24: 768-776, 1994
26. Kawada H, Sumimoto T, Okayama H, Hiwada K: Structure and function of the left ventricle and carotid artery in hemodialysis patients. Hypertens Res 24: 221-227, 2001
27. Krum H, Gilbert RE: Demographics and concomitant disorders in heart failure. Lancet 362: 147-158, 2003
28. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A, Grobbee DE: The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J 22: 1318-1327, 2001
29. De Simone G, Devereux RB: Rationale of echocardiographic assessment of left ventricular wall stress and midwall mechanics in hypertensive heart disease. Eur J Echocardiogr 3: 192-198, 2002
30. Moolgavkar SH, Lee JH, Stevens RG: Analysis of vital statistics data. In: Modern Epidemiology, edited by Rothman KJ, Greenland S, Lippincot-Raven, 1998, pp 481-497
31. Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Boger R: Creed Investigators. Left ventricular hypertrophy, cardiac remodelling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 62: 339-345, 2002
32. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R: Plasma concentration of asymmetric dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358: 2113-2117, 2001
33. Middleton RJ, Parfrey PS, Foley RN: Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12: 1079-1084, 2001
34. Verdecchia P, Schillaci G, Reboldi G, Ambrosio G, Pede S, Porcellati C: Prognostic value of midwall shortening fraction and its relation with left ventricular mass in systemic hypertension. Am J Cardiol 87: 479-482, 2001
35. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D: Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: The cardiovascular health study. J Am Coll Cardiol 37: 1042-1048, 2001
36. Schillaci G, Verdecchia P, Reboldi G, Pede S, Porcellati C: Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-hour blood pressure. Am J Cardiol 86: 509-513, 2000